These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Trimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction. Chen A; Li W; Chen X; Shen Y; Dai W; Dong Q; Li X; Ou C; Chen M BMC Cardiovasc Disord; 2016 Nov; 16(1):225. PubMed ID: 27855650 [TBL] [Abstract][Full Text] [Related]
10. Differential role of rho-kinase in pathological and physiological cardiac hypertrophy in rats. Balakumar P; Singh M Pharmacology; 2006; 78(2):91-7. PubMed ID: 16974135 [TBL] [Abstract][Full Text] [Related]
11. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats. Rose M; Balakumar P; Singh M Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955 [TBL] [Abstract][Full Text] [Related]
12. Impact of obesity on hypertension-induced cardiac remodeling: role of oxidative stress and its modulation by gemfibrozil treatment in rats. Singh R; Singh AP; Singh M; Krishan P Free Radic Biol Med; 2011 Jan; 50(2):363-70. PubMed ID: 21118715 [TBL] [Abstract][Full Text] [Related]
13. Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity. Ryu Y; Jin L; Kee HJ; Piao ZH; Cho JY; Kim GR; Choi SY; Lin MQ; Jeong MH Sci Rep; 2016 Oct; 6():34790. PubMed ID: 27703224 [TBL] [Abstract][Full Text] [Related]
15. Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts. Kumbar DH; VanBergen A; Ocampo C; Muangmingsuk S; Griffin AJ; Gupta M J Appl Physiol (1985); 2007 May; 102(5):2024-32. PubMed ID: 17255372 [TBL] [Abstract][Full Text] [Related]
16. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2. Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309 [TBL] [Abstract][Full Text] [Related]
17. Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway. Wu JB; Zhou Y; Liang CL; Zhang XJ; Lai JM; Ye SF; Ouyang H; Lin J; Zhou JY Chin J Integr Med; 2017 Oct; 23(10):770-778. PubMed ID: 27048408 [TBL] [Abstract][Full Text] [Related]
18. The Role of Calcium-Sensing Receptors in Endothelin-1-Dependent Effects on Adult Rat Ventricular Cardiomyocytes: Possible Contribution to Adaptive Myocardial Hypertrophy. Dyukova E; Schreckenberg R; Arens C; Sitdikova G; Schlüter KD J Cell Physiol; 2017 Sep; 232(9):2508-2518. PubMed ID: 27662515 [TBL] [Abstract][Full Text] [Related]
19. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload. Gravning J; Ahmed MS; von Lueder TG; Edvardsen T; Attramadal H Int J Cardiol; 2013 Oct; 168(3):2049-56. PubMed ID: 23452880 [TBL] [Abstract][Full Text] [Related]
20. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling. Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]